Seizure freedom · patients with drug‐resistant epilepsy
PUFA may leads to higher seizure freedom compared with placebo (low certainty).
1 finding from 1 review
50% reduction in seizures frequency (12 weeks) ‐ Per protocol data ‐ Older (19 years or more) · patients with drug‐resistant epilepsy
PUFA showed no clear difference in 50% reduction in seizures frequency (12 weeks) ‐ Per protocol data ‐… compared with placebo (low certainty).
1 finding from 1 review
50% reduction in seizures frequency (12 weeks) ‐ Per protocol data ‐ Younger (< 19 years) · patients with drug‐resistant epilepsy
PUFA may leads to higher 50% reduction in seizures frequency (12 weeks) ‐ Per protocol data ‐… compared with placebo (low certainty).
1 finding from 1 review
50% or greater reduction in seizure frequency · patients with drug‐resistant epilepsy
PUFA showed no clear difference in 50% reduction in seizures frequency (6 weeks) compared with placebo (moderate certainty).
1 finding from 1 review
Potential adverse effects ‐ not reported · patients with drug‐resistant epilepsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Gastrointestinal effects · patients with drug‐resistant epilepsy
PUFA showed no clear difference in gastrointestinal effects compared with placebo (low certainty).
1 finding from 1 review
Visual acuity · term infants
LCPUFA supplemented formula showed no clear difference in visual acuity/Teller cards at 12 months (cycles/degree) ‐ DHA and AA… compared with control formula (low certainty).
1 finding from 1 review
Sweep VEP acuity at 12 months (LogMAR) ‐ DHA and AA vs normal term formula · term infants
LCPUFA supplemented formula showed no clear difference in sweep VEP acuity at 12 months (LogMAR) ‐ DHA and AA vs normal term… compared with control formula (low certainty).
1 finding from 1 review
MDI scores (Bayley) at 18 months ‐ DHA and AA vs normal term formula · term infants
LCPUFA supplemented formula showed no clear difference in MDI scores (Bayley) at 18 months ‐ DHA and AA vs normal term formula compared with control formula (low certainty).
1 finding from 1 review
PDI scores (Bayley) at 18 months ‐ DHA and AA vs normal term formula · term infants
LCPUFA supplemented formula showed no clear difference in PDI scores (Bayley) at 18 months ‐ DHA and AA vs normal term formula compared with control formula (low certainty).
1 finding from 1 review
Weight (z score) · term infants
LCPUFA supplemented formula showed no clear difference in weight at 12 months (z scores) ‐ DHA and AA vs normal term formula compared with control formula (low certainty).
1 finding from 1 review
Length (cm) · term infants
LCPUFA supplemented formula showed no clear difference in length at 12 months (z scores) ‐ DHA and AA vs normal term formula compared with control formula (low certainty).
1 finding from 1 review
Head circumference at 12 months (z scores) ‐ DHA and AA vs normal term formula · term infants
LCPUFA supplemented formula showed no clear difference in head circumference at 12 months (z scores) ‐ DHA and AA vs normal… compared with control formula (low certainty).
1 finding from 1 review